Superior protection against malaria and melanoma metastases by a C-glycoside analogue of the natural killer T cell ligand alpha-Galactosylceramide - Wikidata - awgldk - TriplyDB

Superior protection against malaria and melanoma metastases by a C-glycoside analogue of the natural killer T cell ligand alpha-Galactosylceramide

Superior protection against malaria and melanoma metastases by a C-glycoside analogue of the natural killer T cell ligand alpha-Galactosylceramide

http://www.wikidata.org/entity/Q36371546

about

Invariant NKT cells as novel targets for immunotherapy in solid tumors C-galactosylceramide: Synthesis and immunology The role of NKT cells in tumor immunity How do natural killer T cells help B cells?Synthetic glycolipid activators of natural killer T cells as immunotherapeutic agents The Role of Invariant Natural Killer T Cells in Dendritic Cell Licensing, Cross-Priming, and Memory CD8(+) T Cell Generation NKT cell networks in the regulation of tumor immunity The regulatory role of invariant NKT cells in tumor immunity Activation of invariant NKT cells exacerbates experimental visceral leishmaniasis Mechanisms for Glycolipid Antigen-Driven Cytokine Polarization by V 14i NKT Cells A Molecular Basis for the Exquisite CD1d-Restricted Antigen Specificity and Functional Responses of Natural Killer T Cells Galactose-modified iNKT cell agonists stabilized by an induced fit of CD1d prevent tumour metastasis.NKT TCR Recognition of CD1d- -C-Galactosylceramide Glycolipids that Elicit IFN-γ-Biased Responses from Natural Killer T Cells Structural and Functional Characterization of a Novel Nonglycosidic Type I NKT Agonist with Immunomodulatory Properties Invariant natural killer T cells and their ligands: focus on multiple sclerosis Improving Mycobacterium bovis bacillus Calmette-Guèrin as a vaccine delivery vector for viral antigens by incorporation of glycolipid activators of NKT cells Alpha-C-galactosylceramide as an adjuvant for a live attenuated influenza virus vaccine.Human natural killer T cells are heterogeneous in their capacity to reprogram their effector functions Establishment of mass spectrometric fingerprints of novel synthetic cholesteryl neoglycolipids: the presence of a unique C-glycoside species during electrospray ionization and during collision-induced dissociation tandem mass spectrometry.A multifactorial mechanism in the superior antimalarial activity of alpha-C-GalCer.Stimulation of natural killer T cells by glycolipids Multiple innate signaling pathways cooperate with CD40 to induce potent, CD70-dependent cellular immunity Lipid and glycolipid antigens of CD1d-restricted natural killer T cells.Glycolipid presentation to natural killer T cells differs in an organ-dependent fashion.Α-galactosylceramide analogs with weak agonist activity for human iNKT cells define new candidate anti-inflammatory agents The stimulating adventure of KRN 7000.A rapid fluorescence-based assay for classification of iNKT cell activating glycolipids.Alpha-galactosylceramide promotes killing of Listeria monocytogenes within the macrophage phagosome through invariant NKT-cell activation Modulation of CD1d-restricted NKT cell responses by using N-acyl variants of alpha-galactosylceramides.Regulation of anthrax toxin-specific antibody titers by natural killer T cell-derived IL-4 and IFNγ.Cytokine dependent and independent iNKT cell activation Distinct and overlapping effector functions of expanded human CD4+, CD8α+ and CD4-CD8α- invariant natural killer T cells Alpha-galactosylceramide as a therapeutic agent for pulmonary Mycobacterium tuberculosis infection.The effect of intracellular trafficking of CD1d on the formation of TCR repertoire of NKT cells.Activated iNKT cells promote memory CD8+ T cell differentiation during viral infection The clinical implication and molecular mechanism of preferential IL-4 production by modified glycolipid-stimulated NKT cells.Antigen-specific cytotoxicity by invariant NKT cells in vivo is CD95/CD178-dependent and is correlated with antigenic potency Influenza infection in suckling mice expands an NKT cell subset that protects against airway hyperreactivity.Glycolipid activation of invariant T cell receptor+ NK T cells is sufficient to induce airway hyperreactivity independent of conventional CD4+ T cells.

P2860

Q21284987-75176AE9-B9DF-482B-A37A-C2D2DCC3F0D1 Q24625835-177B99A4-C25C-49F9-9BFE-081384308E0B Q24648939-353373C4-99F4-4D3B-BA06-C90D424809EF Q24650966-6D87F111-6E3C-427C-A6A0-5E22F2906652 Q26748456-0B2F2E76-2B41-40B7-B48D-D62D0D9681A9 Q26797344-EA7C9D4D-24AA-408B-87F6-032F7AF55D72 Q26866223-05C9618A-1A7A-4592-8DB4-D791844DC958 Q27023425-1E317291-336B-4943-ABDA-C1DE5CBFC61F Q27318814-35F1C4D0-A576-4401-93C5-18373751032E Q27658388-64AA00AD-1317-4117-8029-9EC778F18D0B Q27667168-478FD26D-3BF5-4050-A3FC-FBB12B19E9F2 Q27667759-3A802390-16A3-4208-88AB-47787F70E3BC Q27674653-79CB214D-B16A-42BB-B2B0-BE0148DAACB7 Q27676395-93CE6D4F-D11D-43D9-82D4-9C00FF5B51C5 Q27677017-0AE09B5A-40ED-4450-BF5B-50FE8CE4D6F4 Q28083069-1100339E-FD9D-4F2A-8BB1-235D34CF94F7 Q28543248-9B3A1822-8489-46CF-86A6-3E44C3BD54C3 Q30377447-B7F9C43F-AEF6-4219-BE2F-8248AB0F33FC Q33267309-3F3F743B-9AD0-471E-A48E-E69D4DCBF74D Q33436168-AD2C022B-F56F-4920-8948-7E52ECBD83A4 Q33570532-08527662-0B34-4E3E-BA90-2EB6FB4DE353 Q33599059-02A68197-3A60-4D40-8DA1-0FA302B5A2E9 Q33653495-F02F0F31-3143-46DA-9ED1-033376F22640 Q33724575-70EA5EA4-A7E5-4A09-95EE-2F8641D35FD7 Q33762686-BBA16808-C2C1-4F2C-A9E0-70126616EC99 Q33778356-A3F6D426-FE9F-42F0-85D6-F7DCF023233A Q33843406-41A9F03F-0A8F-4118-BD48-CF631874C1CC Q33852300-FFE688D6-756D-497B-92DC-B046C4BB4F6B Q33877217-CB73B498-DD16-4EB1-B33A-D97A2BEF4E41 Q33927443-23CA4FCB-4539-4BCA-8D92-05BBE946A56C Q34000070-6B8E44D8-AB6E-4E70-9E7B-9DE0E5363847 Q34039891-8CAF6925-6674-45BF-8915-65620986BA4E Q34103244-D0C00673-206D-4173-88BE-91176820158A Q34172161-B47447D5-C282-4134-88D6-300763B47E4A Q34179888-86F68212-DEA7-446F-9B15-C9C3D79157A0 Q34287659-D76A39EC-D2EF-4557-80EF-22D6A42ED622 Q34328138-7218CC51-36A9-46DC-BB05-DE904720E09F Q34338958-E3E45F15-9A65-4742-87C4-843094501E7C Q34429040-3C4DFBE4-5D25-420C-8A93-ECDC25B62412 Q34479554-5597F8FE-86D1-42EB-BF84-18532C914BE5

P2860

Superior protection against malaria and melanoma metastases by a C-glycoside analogue of the natural killer T cell ligand alpha-Galactosylceramide

http://www.wikidata.org/entity/Q36371546

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh

2003年學術文章

@zh-hant

name

Superior protection against ma ...... igand alpha-Galactosylceramide

@ast

Superior protection against ma ...... igand alpha-Galactosylceramide

@en

type

label

Superior protection against ma ...... igand alpha-Galactosylceramide

@ast

Superior protection against ma ...... igand alpha-Galactosylceramide

@en

prefLabel

Superior protection against ma ...... igand alpha-Galactosylceramide

@ast

Superior protection against ma ...... igand alpha-Galactosylceramide

@en

P1433

Q36371546-F84A05DB-42EE-4799-9954-CD7640D3D119

P1476

Q36371546-BACE2BE0-7FD9-4025-BF83-0CD78039ECA2

P2093

Q36371546-1002C500-4A5F-4B9A-8F70-15ADFF366588

Q36371546-18314C2A-C085-4C02-9A81-A1693909C897

Q36371546-8F8FBB52-8E8A-48F0-960B-A8CC782FC47E

P2860

Q36371546-2E99CAD4-8F79-4BB7-ABB4-D6471E083BF7

Q36371546-3D770744-D6F4-40D6-BBDA-A3D598207114

Q36371546-5DD50A35-C342-4388-88B0-2AB663040B25

Q36371546-5E102081-F2CD-4B64-9CC3-7702054B3EB0

Q36371546-7BC1E643-C541-4F55-BBB2-E5F5ACE98F1B

Q36371546-80DF9486-E42F-4B67-A8F2-5C7CFA86242F

Q36371546-878500AF-A70A-41F1-BD6D-F0E45EEB90BB

Q36371546-8B46B546-B702-47A8-A6D3-42BD00CB141A

Q36371546-9C307EE7-B83B-4835-9D41-6463F928CAD5

Q36371546-9F8727BD-35B7-4D07-B1B7-08B4A1FA1E16

P304

Q36371546-13C105E5-DF32-4244-B5FC-39534B81458A

P31

Q36371546-B571C48D-9B25-4328-ACAD-D6A9C7DD89C5

P356

Q36371546-64D7EBF7-4C6F-4B43-8ECA-401A816F526E

P407

Q36371546-E01540CD-564D-4B5D-A5EB-B42EA1305C71

P433

Q36371546-38DCB3EB-DD42-461B-9894-6AE213AE3C5D

P478

Q36371546-C6675AD3-F827-4524-934D-B2B564147F09

P50

Q36371546-9D01E01A-6865-4A7D-B200-E888FAD725AB

P577

Q36371546-92793052-EE19-4E72-8BF5-B4BD20E61E38

P5875

Q36371546-D0F3407E-8B16-4B40-B528-E50FA6E2F6C3

P698

Q36371546-FC46580D-237D-4A59-A225-2D0A0C9418D5

P921

Q36371546-1A860284-E274-42F2-9C7C-B57F9E3810ED

Q36371546-2F41D258-5CE1-4C68-A33A-016E93A3CE10

P932

Q36371546-8C366010-5BDA-421F-9C1B-097D2CBCADC4

P356

P1433

Journal of Experimental Medicine

P1476

Superior protection against ma ...... igand alpha-Galactosylceramide

@en

P2093

Guangli Yang

http://www.w3.org/2001/XMLSchema#string

John Schmieg

http://www.w3.org/2001/XMLSchema#string

Richard W Franck

http://www.w3.org/2001/XMLSchema#string

P2860

CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides

NKT cells: facts, functions and fallacies.

Immunotherapy with ligands of natural killer T cells.

Mouse V alpha 14i natural killer T cells are resistant to cytokine polarization in vivo

The response of natural killer T cells to glycolipid antigens is characterized by surface receptor down-modulation and expansion.

Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers.

Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers

CD1d-mediated recognition of an alpha-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution

alpha -galactosylceramide-activated Valpha 14 natural killer T cells mediate protection against murine malaria

Altered peptide ligand-induced partial T cell activation: molecular mechanisms and role in T cell biology.

P304

1631-1641

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1084/JEM.20031192

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

198

http://www.w3.org/2001/XMLSchema#string

P50

P577

2003-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8975180

http://www.w3.org/2001/XMLSchema#string

P698

14657217

http://www.w3.org/2001/XMLSchema#string

P921

(1R)-1,5-anhydro-1-[(3S,4S,5R)-3-(hexacosanoylamino)-4,5-dihydroxynonadecyl]-D-galactitol

P932

2194137

http://www.w3.org/2001/XMLSchema#string